# Neuphoria Therapeutics Inc.: Form 6-K, filed Nov 3, 2023

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 6-K
- Filed: 2023-11-03
- Accepted by EDGAR: Nov 3, 2023, 10:03 ET
- Period: 2023-11-03
- Accession: 0000950170-23-058491
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000095017023058491/bnox-6k-noticeof2023agm.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000095017023058491/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000095017023058491/bnox-6k-noticeof2023agm.htm

Filed Nov 3, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-058491. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.